BioMarin Pharmaceutical Company Updates | Glassdoor

Company Updates

  • Our cutting-edge research makes us unique while our goal to help the rare disease community brings us together. Watch to learn more about our research approach.

    http://glassdoor.com/slink.htm?key=vQZWj

  • Did you know BioMarin built one of the first gene therapy manufacturing facilities in the world? Located in Novato, California, this site is home to our research pioneers.

  • We’re honored to receive our second recognition by Forbes as a best employer in 2018. This time on a global scale as one of “The World’s Best Employers 2018”!
    http://glassdoor.com/slink.htm?key=vQxcq

    Forbes Names BioMarin Among World's Best Employers

    SAN RAFAEL, Calif., Oct. 11, 2018 / PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced today that Forbes' named the company to its list, Global 2000: World's Best Employers. It is ranked within the top 300 out of a total of 2000 companies and fifth among the nine biotech companies also named.

  • Find out why we believe that speed and purpose are two essential characteristics of the BioMarin DNA! http://glassdoor.com/slink.htm?key=vQZjA

  • At BioMarin we recognize that each and every employee plays a special role in the development of our products. Learn more about how our team makes an impact on patients’ lives! http://glassdoor.com/slink.htm?key=vQZjC

  • We’re proud to have been named one of Forbes "America’s Best Mid-Size Employers" 2018! At BioMarin, we’re committed to creating an inspiring workplace: http://glassdoor.com/slink.htm?key=vQ8Ot

  • http://glassdoor.com/slink.htm?key=vQXq1

    BioMarin to Present at 35th Annual J.P. Morgan Healthcare Conference in San Francisco

    Jan. 3, 2017 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will participate in the 35th Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2017 at 8:30 am PT, or 11:30 am ET, in San Francisco, California .

  • http://glassdoor.com/slink.htm?key=vIhPU

    How Focusing On Obscure Diseases Made BioMarin A $15 Billion Company

    BioMarin became one of the world's most valuable biotechs by jettisoning costly distractions and focusing on one thing: treating some of the rarest diseases on the planet.

  • http://glassdoor.com/slink.htm?key=vIMPe

    BioMarin Announces BioMarin RareConnections™ Services for Eligible Rare Disease Patients

    BioMarin Pharmaceutical Inc. announced today the launch of BioMarin RareConnectionsTM, rebranding its patient-focused offering formally known as the BioMarin Patient and Physician Support (BPPS).

  • http://glassdoor.com/slink.htm?key=vIQkC

    Will 2016 Be BioMarin Pharmaceutical's Best Year Yet? -- The Motley Fool

    ( BioMarin Pharmaceutical NASDAQ:BMRN) has been one of the fastest growing mid-cap biopharmas over the last few years. Since 2010, for example, the drugmaker's stock has outperformed even the red-hot iShares Nasdaq Biotechnology ETF:

Work at BioMarin Pharmaceutical? Share Your Experiences

BioMarin Pharmaceutical
  • Star
  • Star
  • Star
  • Star
  • Star
 
Click to Rate
or